Animal Vaccines Market by Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines), Animal Type (Aqua, Companion, Poultry) - Global Forecast 2024-2030
The Animal Vaccines Market size was estimated at USD 16.39 billion in 2023 and expected to reach USD 17.75 billion in 2024, at a CAGR 8.34% to reach USD 28.72 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Animal Vaccines Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Animal Vaccines Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Animal Vaccines Market, highlighting leading vendors and their innovative profiles. These include Anicon Labor GmbH by SAN Group, Biogénesis Bagó S.A., Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private limited, Ceva Santé Animale, China Animal Husbandry Industry Co., Ltd., Dalan Animal Health., Eli Lilly and Company, Endovac Animal Health, LLC, Heska Corporation, Hester Biosciences Limited, HIPRA, S.A., Indian Immunologicals Limited, Merck KGaA, Neogen Corporation, Pfizer Inc., Phibro Animal Health Corporation, Sanofi S.A., Torigen Pharmaceuticals Inc., Vaxxinova GmbH, VEROVACCiNES GmbH, Vetigenics, Vetoquinol SA, Virbac, Inc., and Zoetis Inc..
Market Segmentation & Coverage
This research report categorizes the Animal Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Attenuated Live Vaccines
Aqua
Aeromonas
Canine
Canine Herpes
Calicivirus
Avian Influenza
Coronavirus Ruminants
Americas
Argentina
California
Australia
Denmark
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast of the Animal Vaccines Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Animal Vaccines Market?
- What are the technology trends and regulatory frameworks in the Animal Vaccines Market?
- What is the market share of the leading vendors in the Animal Vaccines Market?
- Which modes and strategic moves are suitable for entering the Animal Vaccines Market?
Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Animal Vaccines Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing Livestock Population
- 5.1.1.2. Rising Animal Husbandry along with Commercialization of Animal Products
- 5.1.1.3. Increasing Incidences of Zoonotic Diseases
- 5.1.2. Restraints
- 5.1.2.1. Supply End Costs are Relatively High, with Poorer Capital Returns than Human Vaccines
- 5.1.3. Opportunities
- 5.1.3.1. Shift from Live Attenuated Vaccines to DNA Vaccines
- 5.1.3.2. Continuous Technological Advancements in Vaccines
- 5.1.4. Challenges
- 5.1.4.1. Adverse Impacts of Vaccines
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Animal Vaccines Market, by Product
- 6.1. Introduction
- 6.2. Attenuated Live Vaccines
- 6.3. DNA Vaccines
- 6.4. Inactivated Vaccines
- 6.5. Recombinant Vaccines
- 6.6. Subunit Vaccines
- 7. Animal Vaccines Market, by Animal Type
- 7.1. Introduction
- 7.2. Aqua
- 7.3.1. Aeromonas
- 7.3.2. Streptococcosis
- 7.3.3. Vibrio
- 7.3. Companion
- 7.4.1. Canine
- 7.4.2.1. Canine Herpes
- 7.4.2.2. Distemper
- 7.4.2.3. Kennel Cough
- 7.4.2.4. Lyme Disease
- 7.4.2.5. Parvovirus
- 7.4.2.6. Rabies Canine
- 7.4.2. Feline
- 7.4.3.1. Calicivirus
- 7.4.3.2. Coronavirus Feline
- 7.4.3.3. Panleukopenia
- 7.4.3.4. Rabies Feline
- 7.4.3.5. Rhinotracheitis
- 7.4. Poultry
- 7.5.1. Avian Influenza
- 7.5.2. Infectious Bronchitis
- 7.5.3. Marek's Disease
- 7.5.4. Newcastle Disease
- 7.5.5. Salmonella
- 7.5. Ruminants
- 7.6.1. Coronavirus Ruminants
- 7.6.2. E. Coli
- 7.6.3. Foot & mouth disease (FMD)
- 7.6.4. Lumpy skin
- 7.6.5. Rotavirus
- 8. Americas Animal Vaccines Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
- 9. Asia-Pacific Animal Vaccines Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
- 10. Europe, Middle East & Africa Animal Vaccines Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
- 11. Competitive Landscape
- 11.1. FPNV Positioning Matrix
- 11.2. Market Share Analysis, By Key Player
- 11.3. Competitive Scenario Analysis, By Key Player
- 12. Competitive Portfolio
- 12.1. Key Company Profiles
- 12.1.1. Anicon Labor GmbH by SAN Group
- 12.1.2. Biogénesis Bagó S.A.
- 12.1.3. Boehringer Ingelheim International GmbH
- 12.1.4. Brilliant Bio Pharma Private limited
- 12.1.5. Ceva Santé Animale
- 12.1.6. China Animal Husbandry Industry Co., Ltd.
- 12.1.7. Dalan Animal Health.
- 12.1.8. Eli Lilly and Company
- 12.1.9. Endovac Animal Health, LLC
- 12.1.10. Heska Corporation
- 12.1.11. Hester Biosciences Limited
- 12.1.12. HIPRA, S.A.
- 12.1.13. Indian Immunologicals Limited
- 12.1.14. Merck KGaA
- 12.1.15. Neogen Corporation
- 12.1.16. Pfizer Inc.
- 12.1.17. Phibro Animal Health Corporation
- 12.1.18. Sanofi S.A.
- 12.1.19. Torigen Pharmaceuticals Inc.
- 12.1.20. Vaxxinova GmbH
- 12.1.21. VEROVACCiNES GmbH
- 12.1.22. Vetigenics
- 12.1.23. Vetoquinol SA
- 12.1.24. Virbac, Inc.
- 12.1.25. Zoetis Inc.
- 12.2. Key Product Portfolio
- 13. Appendix
- 13.1. Discussion Guide
- 13.2. License & Pricing
- FIGURE 1. ANIMAL VACCINES MARKET RESEARCH PROCESS
- FIGURE 2. ANIMAL VACCINES MARKET SIZE, 2023 VS 2030
- FIGURE 3. ANIMAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. ANIMAL VACCINES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. ANIMAL VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. ANIMAL VACCINES MARKET DYNAMICS
- FIGURE 7. ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 8. ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
- FIGURE 10. ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. AMERICAS ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 12. AMERICAS ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 14. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ANIMAL VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 20. ANIMAL VACCINES MARKET SHARE, BY KEY PLAYER, 2023
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook